[MYGN] YoY Quarter Result on 31-Mar-2013 [#Q1]

Stock
[MYGN] Myriad Genetics, Inc.
Announcement Date
08-May-2013
Financial Year
2013
Quarter
31-Mar-2013 [#Q1]
Profit Trend
QoQ- 8.15%
YoY- 27.95%
Quarter Report
MYGN's Result
MYGN's Financial Summary
View:
Show?
Quarter Result
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
Revenue 190,500 179,985 182,924 156,472 129,777 102,374 90,830 13.12%
PBT 43,100 35,566 57,343 59,241 47,481 42,312 34,480 3.78%
Tax 10,500 14,091 20,573 21,349 17,866 14,372 1,229 42.93%
NP 32,600 21,475 36,770 37,892 29,615 27,940 33,251 -0.32%
Tax Rate -24.36% -39.62% -35.88% -36.04% -37.63% -33.97% -3.56% -
Total Cost 157,900 158,510 146,154 118,580 100,162 74,434 57,579 18.29%
Ratio Analysis
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
NP Margin 17.11 11.93 20.10 24.22 22.82 27.29 36.61 -11.89%
Per Share
31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 31/03/10 CAGR
EPS 0.49 0.30 0.50 0.47 0.35 0.32 0.34 6.27%
EPS Diluted 0.47 0.29 0.48 0.46 0.34 0.31 0.33 6.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.